Sweetch

Sweetch is a company headquartered in Israel. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Sweetch provides an AI- and emotionally-intelligent engagement platform and digital therapeutic that delivers hyper-personalized, just-in-time interventions to improve adherence and outcomes for people with chronic conditions, notably Type 2 diabetes using CGM and patient-reported data. The company partners with healthcare organizations, pharma, device manufacturers and payers to drive behavior change and remote patient monitoring.